
|Articles|January 18, 2008
FDA: User fee for review of DTC ads for drugs is mothballed
FDA's user fee program for review of DTC TV ads for Rx drug, biologic products will not be implemented
Advertisement
The Food & Drug Administration has issued a notice in the Jan. 16 Federal Register informing companies that the direct-to-consumer (DTC) television advertisement user fee program will not commence because the necessary user fees for the program were not "provided in advance in appropriations acts" as required by the FDA Amendments Act of 2007 (FDAAA). So the previously issued notice establishing user fee rates for the program for fiscal year (FY) 2008 is being withdrawn. For more information, e- mail
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























